The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study

IY Hachim, MY Hachim, H Hannawi, KB Naeem… - PLoS …, 2021 - journals.plos.org
Several reports highlighted the central role of inflammation in the pathogenesis of corona
virus disease-19 (COVID-19) disease. Also, the hyper-inflammatory response that is …

[HTML][HTML] The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis

RK Mahat, S Panda, V Rathore, S Swain… - … epidemiology and global …, 2021 - Elsevier
Abstract Background Coronavirus disease-2019 (COVID-19) is a global pandemic and high
mortality rate among severe or critical COVID-19 is linked with SARS-CoV-2 infection …

[HTML][HTML] Association of inflammatory markers with the severity of COVID-19: A meta-analysis

F Zeng, Y Huang, Y Guo, M Yin, X Chen, L Xiao… - International Journal of …, 2020 - Elsevier
Objectives Studies reported associations of inflammatory markers with the severity of COVID-
19, but conclusions were inconsistent. We aimed to provide an overview of the association …

Prognostic value of inflammatory biomarkers in patients with severe COVID-19: A single-center retrospective study

G Açıksarı, M Koçak, Y Çağ, LN Altunal… - Biomarker …, 2021 - journals.sagepub.com
Background: The current knowledge about novel coronavirus-2019 (COVID-19) indicates
that the immune system and inflammatory response play a crucial role in the severity and …

Association of inflammatory biomarker abnormalities with mortality in COVID-19: a meta-analysis

A Suri, NK Singh, V Perumal - Bulletin of the National Research Centre, 2022 - Springer
Background COVID-19 outbreak has engulfed different parts of the world, affecting more
than 163 million people and causing more than 3 million deaths worldwide due to human …

[HTML][HTML] Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia

IB Prasetya, JO Lorens, V Sungono… - … and Global Health, 2021 - Elsevier
Background & aims Coronavirus disease 2019 (COVID-19) has a wide clinical spectrum,
ranging from asymptomatic infection to severe diseases with high mortality rate. Early …

[HTML][HTML] Association of inflammatory markers with COVID-19 outcome among hospitalized patients: Experience from a tertiary healthcare center in western India

V Sakthivadivel, GK Bohra, N Maithilikarpagaselvi… - Maedica, 2021 - ncbi.nlm.nih.gov
Introduction: COVID-19 is a highly infectious disease and varies in the severity of
presentation as well as survival outcome due to varied inflammatory responses. Hence, the …

Inflammatory biomarkers associated with in-hospital mortality in critical COVID-19 patients

K Pál, AA Molnar, A Huțanu, J Szederjesi… - International Journal of …, 2022 - mdpi.com
The COVID-19 pandemic poses global healthcare challenges due to its unpredictable
clinical course. The aim of this study is to identify inflammatory biomarkers and other routine …

Differences in leucocytes and inflammation-based indices among critically ill patients owing to SARS-CoV-2 variants during several successive waves of COVID-19 …

AB Jemaa, R Oueslati, J Guissouma… - International …, 2023 - Elsevier
Abstract Background/Aim Inflammatory indices are useful informative markers in assessing
the severity of the COVID-19 disease course; however, their involvements during series …

The role of biomarkers in hospitalized COVID-19 patients with systemic manifestations

M Schneider - Biomarker Insights, 2022 - journals.sagepub.com
The following article aims to review COVID-19 biomarkers used in hospital practice. It is
apparent that COVID-19 is not simply a pulmonary disease but has systemic manifestations …